Literature DB >> 11739369

Allowing for uncertainty in economic evaluations: qualitative sensitivity analysis.

D Walker1, J Fox-Rushby.   

Abstract

Sensitivity analysis allows analysts to explore the impact of uncertainty on their findings. It is an important part of any economic evaluation, and a lack of analysis is evidence of a poor quality study. Sensitivity analysis helps the analyst evaluate the reliability of conclusions for the context of the evaluation and can also facilitate consideration of the generalizability of results to other settings. The variety of one and multi-way sensitivity analyses offer simple and complementary approaches to evaluating the impact of uncertainty on the results and conclusions of economic evaluations. The paper begins with a brief discussion of the types of uncertainty that can arise in economic evaluation, and follows with suggestions of how to plan a justified sensitivity analysis. A number of specific techniques are worked through with examples, followed by a discussion of when it is best to use them. The main weakness associated with sensitivity analysis is the control that the analyst retains over three parts of the process: the choice of which variables to vary and which to treat as known or fixed; the amount of variation around the base value of the parameter that is considered clinically meaningful or policy-relevant; and the determination of what constitutes a sensitive or robust finding. It is therefore essential that the approach of the analyst is clear and justified. It is likely that the future will see further developments in the approaches and training of statistical analysis. But in the meantime, an increase in the number of evaluators undertaking a wider range of sensitivity analysis would improve the quality of evidence for, and outcomes of, decision-making.

Entities:  

Mesh:

Year:  2001        PMID: 11739369     DOI: 10.1093/heapol/16.4.435

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  15 in total

Review 1.  Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.

Authors:  Sun-Young Kim; Sue J Goldie
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

2.  A square peg in a round hole? Challenges with DALY-based "burden of disease" calculations in surgery and a call for alternative metrics.

Authors:  Richard Gosselin; Doruk Ozgediz; Dan Poenaru
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

3.  Using real world evidence to generate cost-effectiveness analysis of fibrinolytic therapy in patients with ST-segment elevation myocardial infarction in Thailand.

Authors:  Krittimeth Trerayapiwat; Peerawat Jinatongthai; Prin Vathesatogkit; Piyamitr Sritara; Ninutcha Paengsai; Piyameth Dilokthornsakul; Surakit Nathisuwan; Lan My Le; Nathorn Chaiyakunapruk
Journal:  Lancet Reg Health West Pac       Date:  2022-06-24

4.  Economic evaluation of a task-shifting intervention for common mental disorders in India.

Authors:  Christine Buttorff; Rebecca S Hock; Helen A Weiss; Smita Naik; Ricardo Araya; Betty R Kirkwood; Daniel Chisholm; Vikram Patel
Journal:  Bull World Health Organ       Date:  2012-09-14       Impact factor: 9.408

5.  Single-dose versus multiple-dose antibiotic prophylaxis for the surgical treatment of closed fractures.

Authors:  Gerard P Slobogean; Peter J O'Brien; Carmen A Brauer
Journal:  Acta Orthop       Date:  2010-04       Impact factor: 3.717

6.  Comparison of costs of home and facility-based basic obstetric care in rural Bangladesh.

Authors:  J Borghi; N Sabina; C Ronsmans; J Killewo
Journal:  J Health Popul Nutr       Date:  2010-06       Impact factor: 2.000

7.  Barriers and opportunities for evidence-based health service planning: the example of developing a Decision Analytic Model to plan services for sexually transmitted infections in the UK.

Authors:  Catherine R H Aicken; Nigel T Armstrong; Jackie A Cassell; Neil Macdonald; Angela C Bailey; Sandra A Johnson; Catherine H Mercer
Journal:  BMC Health Serv Res       Date:  2012-07-17       Impact factor: 2.655

8.  Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial.

Authors:  Edward Day; Alex Copello; Jennifer L Seddon; Marilyn Christie; Deborah Bamber; Charlotte Powell; Sanju George; Andrew Ball; Emma Frew; Nicholas Freemantle
Journal:  Trials       Date:  2013-08-19       Impact factor: 2.279

9.  Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies.

Authors:  Abdulkareem J Al-Quwaidhi; Mark S Pearce; Eugene Sobngwi; Julia A Critchley; Martin O'Flaherty
Journal:  Diabetes Res Clin Pract       Date:  2014-01-03       Impact factor: 5.602

10.  Economic evaluations of non-communicable disease interventions in developing countries: a critical review of the evidence base.

Authors:  Jo-Ann Mulligan; Damian Walker; Julia Fox-Rushby
Journal:  Cost Eff Resour Alloc       Date:  2006-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.